Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$40.90

0.08 (0.20%)

, HSBC

HSBC

$46.41

-0.77 (-1.63%)

06:07
08/07/18
08/07
06:07
08/07/18
06:07

GlaxoSmithKline names HSBC exec Iain Mackay as CFO

GlaxoSmithKline (GSK) announced that Iain Mackay has been appointed GSK's next CFO. He has also been appointed as an Executive Director to the GSK Board. Mackay will join the company on January 14, 2019. Mackay joins GSK from the global bank HSBC (HSBC), where he has been Group Finance Director for the last 8 years. GSK announced in May that the Company's CFO, Simon Dingemans, is to retire from the company in May 2019. Simon Dingemans will continue to be accountable as CFO for GSK's financial governance through March 2019. There will be a transition period from January 14 when Mackay is CFO Designate, with him taking formal accountability as CFO from April 1. Mackay will join the Corporate Executive Team and the Board from January 14.

GSK

GlaxoSmithKline

$40.90

0.08 (0.20%)

HSBC

HSBC

$46.41

-0.77 (-1.63%)

GSK GlaxoSmithKline
$40.90

0.08 (0.20%)

06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/28/18
WELS
06/28/18
NO CHANGE
WELS
Wells says Amazon deal, Walgreens results have negative read for drug pricing
After Amazon (AMZN) agreed to acquire online pharmacy PillPack, reportedly for $1B, Wells Fargo analyst David Maris noted that he has long stated that Amazon would enter the pharmacy business and warned about the risk to drug pricing in such a scenario. Maris also noted that Walgreens (WBA) reported its U.S. retail pharmacy comparable store sales fell 1.2% in Q3, adding that retailers tend to push drugmakers on price when they feel pressure and the read-through from its report may be negative for drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/25/18
WELS
07/25/18
NO CHANGE
WELS
Market Perform
Even minor delays can hurt Mylan's generic Advair opportunity, says Wells Fargo
After GlaxoSmithKline (GSK) reported U.S. Advair sales declined 43% at constant currency in Q2, Wells Fargo analyst David Maris commented on the read-through to the generic Advair opportunity being pursued by Mylan (MYL). Given the substantial declines branded Advair faces, he said that "even minor delays" can continue to hurt the potential generic opportunity, adding that he has not seen or been notified of any updates from Mylan on Advair since the company was notified in early June that the FDA planned to issue an official Complete Response Letter related to its application. Maris keeps a Market Perform rating on Mylan shares.
HSBC HSBC
$46.41

-0.77 (-1.63%)

05/07/18
LYON
05/07/18
UPGRADE
LYON
Buy
HSBC upgraded to Buy from Outperform at CLSA
07/10/18
JPMS
07/10/18
UPGRADE
JPMS
Overweight
HSBC upgraded to Overweight from Neutral at JPMorgan
07/11/18
JPMS
07/11/18
UPGRADE
JPMS
Overweight
JPMorgan sees value in HSBC after pullback, upgrades to Overweight
JPMorgan analyst Katherine Lei last night upgraded HSBC to Overweight from Neutral and raised her price target for the shares to HKD 92 from HKD 88. Despite stable asset quality and an improving net interest margin outlook, HSBC's share price corrected 14% from the peak in January, Lei tells investors in a research note. The analyst sees value in the shares at current levels.
07/11/18
07/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Myriad Genetics (MYGN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw saying the core HCT business is showing more durability, with volumes returning to growth and price declines slowing, while the acquisitions of Assurex and Counsyl are diversifying the company into higher growth and improving average selling price testing markets. 2. HSBC (HSBC) upgraded to Overweight from Neutral at JPMorgan with analyst Katherine Lei saying despite stable asset quality and an improving net interest margin outlook, HSBC's share price corrected 14% from the peak in January. 3. Conn's (CONN) upgraded to Buy from Hold at Stifel with analyst John Baugh saying he left a recent meeting with management feeling confident that the recent indications of improvement in the credit segment should continue. 4. TripAdvisor (TRIP) upgraded to Overweight from Equal Weight at Barclays with analyst Deepak Mathivanan saying the company's fundamentals "are starting to turn around." 5. Imperial Oil (IMO) upgraded to Equal Weight from Underweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:27
11/20/18
11/20
17:27
11/20/18
17:27
Hot Stocks
MDU Resources sees 2019-2023 CapEx $2.6B »

"We have identified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:26
11/20/18
11/20
17:26
11/20/18
17:26
Earnings
MDU Resources narrows FY18 EPS view to $1.30-$1.45 from $1.25-$1.45 

FY18 consensus $1.39.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:22
11/20/18
11/20
17:22
11/20/18
17:22
Earnings
Foot Locker backs FY18 EPS growth view in double digits, consensus $4.48 »

Backs FY18 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:19
11/20/18
11/20
17:19
11/20/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker sees Q4 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:17
11/20/18
11/20
17:17
11/20/18
17:17
Hot Stocks
Foot Locker says women's business was the strongest in footwear »

Says pleased by Foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CPRT

Copart

$47.30

-1.255 (-2.58%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Earnings
Copart reports Q1 fully diluted EPS 47c, consensus 47c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Hot Stocks
DexCom and Verily amend license agreementAlphabet Class A »

DexCom (DXCM) and Verily,…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

VNET

21Vianet

$11.20

-0.1 (-0.88%)

17:12
11/20/18
11/20
17:12
11/20/18
17:12
Earnings
21Vianet reports Q3 adjusted EBITDA up 81.6% to RMB 45.2M »

Reports Q3 revenue RMB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

DXCM

DexCom

$119.89

-1.34 (-1.11%)

17:05
11/20/18
11/20
17:05
11/20/18
17:05
Syndicate
Breaking Syndicate news story on DexCom »

DexCom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

, ESV

Ensco

$6.19

-0.36 (-5.50%)

17:02
11/20/18
11/20
17:02
11/20/18
17:02
Hot Stocks
Rowan Companies and Ensco granted early termination of waiting period »

Rowan Companies (RDC) and…

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

ESV

Ensco

$6.19

-0.36 (-5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMBK

SmartFinancial

$20.14

-0.56 (-2.71%)

17:00
11/20/18
11/20
17:00
11/20/18
17:00
Hot Stocks
SmartFinancial authorizes $10M stock repurchase plan »

SmartFinancial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RJF

Raymond James

$74.72

-3.195 (-4.10%)

16:55
11/20/18
11/20
16:55
11/20/18
16:55
Hot Stocks
Breaking Hot Stocks news story on Raymond James »

Raymond James reports AUM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.61

-0.28 (-1.66%)

16:53
11/20/18
11/20
16:53
11/20/18
16:53
Hot Stocks
Fulton Financial approves $75M stock repurchase program »

Fulton Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.10

-8.7 (-4.68%)

, VZ

Verizon

$59.46

-1.17 (-1.93%)

16:49
11/20/18
11/20
16:49
11/20/18
16:49
Periodicals
Apple pulls Tumblr app due to offensive images, TNW says »

The app for the blogging…

AAPL

Apple

$177.10

-8.7 (-4.68%)

VZ

Verizon

$59.46

-1.17 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

UNVR

Univar

$21.83

-0.7 (-3.11%)

16:46
11/20/18
11/20
16:46
11/20/18
16:46
Hot Stocks
Univar opens new sales center in Colombia »

Univar announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$6.85

0.05 (0.74%)

16:41
11/20/18
11/20
16:41
11/20/18
16:41
Hot Stocks
Bluestone Financial reports 6.31% stake in McClatchy »

The Reporting Person…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
11/20/18
11/20
16:38
11/20/18
16:38
General news
API crude inventories for week of November 16 »

API reports that crude…

ERA

Era Group

$10.82

0.12 (1.12%)

16:33
11/20/18
11/20
16:33
11/20/18
16:33
Hot Stocks
Era Group names Crystal Gordon SVP General Counsel, Chief Administrative Officer »

Era Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOM

ChannelAdvisor

$10.44

-0.12 (-1.14%)

16:31
11/20/18
11/20
16:31
11/20/18
16:31
Hot Stocks
ChannelAdvisor, Interpark announce new strategic partnership »

ChannelAdvisor announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

ABC

AmerisourceBergen

$88.87

-1.99 (-2.19%)

16:30
11/20/18
11/20
16:30
11/20/18
16:30
Syndicate
Breaking Syndicate news story on AmerisourceBergen »

AmerisourceBergen files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

16:30
11/20/18
11/20
16:30
11/20/18
16:30
Options
Preliminary option volume of 24.3M today »

Preliminary option volume…

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

16:27
11/20/18
11/20
16:27
11/20/18
16:27
Hot Stocks
Breaking Hot Stocks news story on Autodesk »

Autodesk up 8% to $133.23…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

  • 04

    Dec

HOLX

Hologic

$41.29

-0.29 (-0.70%)

16:23
11/20/18
11/20
16:23
11/20/18
16:23
Hot Stocks
Hologic VP Allison Bebo sells 6,500 shares of company stock »

Hologic VP Allison Bebo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:23
11/20/18
11/20
16:23
11/20/18
16:23
Earnings
Caleres lowers FY18 adj. EPS view to $2.25-$2.35 from $2.40-$2.50 »

Consensus $2.46. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

K

Kellogg

$61.72

0.03 (0.05%)

16:22
11/20/18
11/20
16:22
11/20/18
16:22
Hot Stocks
Kellogg CFO acquires 8,190 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.